The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer

Published:2015-04 Issue:1 Volume:137 Page:173-179
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Mabuchi Seiji,Kuroda Hiromasa^ORCID,Takahashi Ryoko,Sasano Tomoyuki^ORCID

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference39 articles.

1. Cancer statistics, 2014;Siegel;CA Cancer J. Clin.,2014

2. Rethinking ovarian cancer: recommendations for improving outcomes;Vaughan;Nat. Rev. Cancer,2011

3. PI3K and cancer: lessons, challenges and opportunities;Fruman;Nat. Rev. Drug Discov.,2014

4. Frequent mutation of the PIK3CA gene in ovarian and breast cancers;Levine;Cancer Res.,2005

5. The phosphatidylinositol 3′-kinase p85alpha gene is an oncogene in human ovarian and colon tumors;Philp;Cancer Res.,2001

Cited by 338 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melatonin changes energy metabolism and reduces oncogenic signaling in ovarian cancer cells;Molecular and Cellular Endocrinology;2024-10

2. Targeting the Akt signaling pathway: Exploiting curcumin's anticancer potential;Pathology - Research and Practice;2024-09

3. Melatonin effect on breast and ovarian cancers by targeting the PI3K/Akt/mTOR pathway;IUBMB Life;2024-08-30

4. The unique metabolome of clear cell ovarian carcinoma;The Journal of Pathology;2024-08-03

5. Enhancing carboplatin sensitivity in ovarian cancer cells by blocking the mercapturic acid pathway transporter;Carcinogenesis;2024-07-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP